通过早期的高质量疾病缓解,完全消除AML中高白细胞瘤风险
Guoqing Lyu1,2,3,4, Wenting Lyu5
1Department of Hematology, the First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
Frontiers in oncology
|June 28, 2024
概括
为诊断患有高白细胞症 (HL) 的急性髓性白血病,建议较低的白细胞计数值为75×10^9/L,从而改善早期干预. 像Bcl2抑制剂这样的向疗法在降低与HL相关的风险方面表现有前途.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 患有高白细胞症 (HL) 的急性髓性白血病 (AML) 是一种具有高死亡率的严重医疗紧急情况.
- 及时诊断和紧急治疗对于改善患者的治疗结果至关重要.
研究的目的:
- 为了确定HL在AML中确切的诊断值.
- 为了研究驱动HL的分子机制.
- 为了确定有效的针对性治疗AML与HL.
主要方法:
- 使用X-tile软件与TCGA和TARGET反洗钱数据库来确定WBC计数值.
- 使用METASCAPE和基因组丰富分析 (GSEA) 进行分子机制探索.
- 使用CELLMINER平台识别了潜在的向药物.
主要成果:
- 为诊断HL,建议对成人进行75×10^9/L和小儿AML的165×10^9/L的修订WBC值.
- 确定了HL与NPM1,FLT3和DNMT3A.突变之间的显著遗传相关性.
- 参与HL的细胞粘附分子的降低调节; Bcl2和基因素脱乙酶抑制剂被确定为潜在的向疗法.
结论:
- 降低HL诊断值有助于早期干预和降低风险.
- 实现深度缓解显著改善HL患者的生存结果.
- 将向疗法 (例如,Bcl2抑制剂) 与传统治疗相结合,为管理AML与HL提供了一个有希望的策略.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.0K
14:51Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
3.2K
相关概念视频
Bone Marrow Sampling and Transplants
324
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
324
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Disorders of Leukocytes
935
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
935
